97 related articles for article (PubMed ID: 32033851)
1. Glycemic variability and all-cause mortality in patients with diabetes receiving hemodialysis: A prospective cohort study.
Shi C; Liu S; Yu HF; Han B
J Diabetes Complications; 2020 Apr; 34(4):107549. PubMed ID: 32033851
[TBL] [Abstract][Full Text] [Related]
2. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis.
Shurraw S; Majumdar SR; Thadhani R; Wiebe N; Tonelli M;
Am J Kidney Dis; 2010 May; 55(5):875-84. PubMed ID: 20346561
[TBL] [Abstract][Full Text] [Related]
4. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
[TBL] [Abstract][Full Text] [Related]
5. Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study.
Yoo DE; Park JT; Oh HJ; Kim SJ; Lee MJ; Shin DH; Han SH; Yoo TH; Choi KH; Kang SW
PLoS One; 2012; 7(1):e30072. PubMed ID: 22291903
[TBL] [Abstract][Full Text] [Related]
6. Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
Götz AK; Böger CA; Popal M; Banas B; Krämer BK
Nephron Clin Pract; 2008; 109(3):c154-60. PubMed ID: 18663328
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin A1c in hemodialysis patients: should one size fit all?
Ix JH
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
[No Abstract] [Full Text] [Related]
8. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
[TBL] [Abstract][Full Text] [Related]
9. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
[TBL] [Abstract][Full Text] [Related]
10. The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease.
Savu O; Elian V; Steriade O; Teodoru I; Mihut S; Tacu C; Covic A; Serafinceanu C
Int Urol Nephrol; 2016 Feb; 48(2):265-70. PubMed ID: 26725077
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic hemodialysis.
Yusof Khan AHK; Zakaria NF; Zainal Abidin MA; Kamaruddin NA
Medicine (Baltimore); 2021 Jul; 100(30):e26729. PubMed ID: 34397709
[TBL] [Abstract][Full Text] [Related]
12. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.
Drechsler C; Kalim S; Wenger JB; Suntharalingam P; Hod T; Thadhani RI; Karumanchi SA; Wanner C; Berg AH
Kidney Int; 2015 Jun; 87(6):1201-8. PubMed ID: 25671766
[TBL] [Abstract][Full Text] [Related]
13. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study.
Oomichi T; Emoto M; Tabata T; Morioka T; Tsujimoto Y; Tahara H; Shoji T; Nishizawa Y
Diabetes Care; 2006 Jul; 29(7):1496-500. PubMed ID: 16801568
[TBL] [Abstract][Full Text] [Related]
14. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.
Saulnier PJ; Gand E; Ragot S; Ducrocq G; Halimi JM; Hulin-Delmotte C; Llaty P; Montaigne D; Rigalleau V; Roussel R; Velho G; Sosner P; Zaoui P; Hadjadj S;
Diabetes Care; 2014 May; 37(5):1425-31. PubMed ID: 24623026
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in Brazilian diabetic patients starting dialysis: a 3.6-year follow-up study.
Bruno RM; Gross JL
J Diabetes Complications; 2000; 14(5):266-71. PubMed ID: 11113689
[TBL] [Abstract][Full Text] [Related]
16. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytopenia predicts mortality in Chinese hemodialysis patients- an analysis of the China DOPPS.
Zhao X; Niu Q; Gan L; Hou FF; Liang X; Ni Z; Chen X; Chen Y; McCullough K; Robinson B; Zuo L
BMC Nephrol; 2022 Jan; 23(1):11. PubMed ID: 34979949
[TBL] [Abstract][Full Text] [Related]
18. Glycemic control is a predictor of survival for diabetic patients on hemodialysis.
Morioka T; Emoto M; Tabata T; Shoji T; Tahara H; Kishimoto H; Ishimura E; Nishizawa Y
Diabetes Care; 2001 May; 24(5):909-13. PubMed ID: 11347753
[TBL] [Abstract][Full Text] [Related]
19. [Assessment and follow up of diabetic patients in hemodialysis].
Sanhueza ME; Cotera A; Elgueta L; López S G; Loncon P; Macan F; Pérez F; Cavada G; Alvo M
Rev Med Chil; 2008 Mar; 136(3):279-86. PubMed ID: 18575652
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control and survival of diabetic hemodialysis patients--importance of lower hemoglobin A1C levels.
Ishimura E; Okuno S; Kono K; Fujino-Kato Y; Maeno Y; Kagitani S; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
Diabetes Res Clin Pract; 2009 Mar; 83(3):320-6. PubMed ID: 19135755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
